The significant $5 billion penalty and sweeping privacy reforms imposed by the Federal Trade Commission (FTC) on Meta (formerly Facebook) serve as a stark reminder of the financial and reputational risks companies face when they disregard shareholder concerns, particularly those raised through formal proposals. While public discourse often focuses on the regulatory actions themselves, it frequently overlooks the fact that these risks were flagged by shareholders well in advance of the penalties. This pattern of dismissal, followed by substantial financial repercussions, is not an isolated incident, as evidenced by significant settlements involving Johnson & Johnson and Monsanto (now part of Bayer) in 2026, collectively costing these corporations and their shareholders over $30 billion.
A History of Ignored Alerts: Meta’s Privacy Reckoning
In 2018, a pivotal moment occurred when shareholders at Meta submitted a proposal urging the company to establish a dedicated Risk Oversight Board Committee. The objective was to proactively address privacy and data security risks that posed a significant threat to shareholder value. Meta’s management, however, opposed this measure, asserting that the existing audit committee provided sufficient oversight. This stance was heavily influenced by Meta’s dual-class share structure, where CEO Mark Zuckerberg, despite holding only a minority of the economic ownership, wielded overwhelming voting power through his substantial Class B shares. Consequently, the shareholder proposal garnered only 11.55% of the total vote, though it represented a notable 45% support among non-insider shareholders.
The following year, the FTC’s landmark $5 billion fine and its mandate for an independent privacy committee with decisive control over user privacy decisions effectively mirrored the substance of the shareholders’ 2018 proposal, albeit with a severe financial penalty. The FTC order stipulated the appointment of compliance officers responsible for Meta’s privacy program, who would report directly to the newly formed privacy committee and could only be removed by it. This regulatory intervention highlighted the foresight of the shareholder proponents, who had sought a similar governance structure to mitigate risks that ultimately materialized with devastating financial consequences for the company and its investors.
Johnson & Johnson: Talc Litigation and Missed Warnings
The costly fallout from the talcum powder litigation facing Johnson & Johnson (J&J) further illustrates the dangers of dismissing shareholder alerts. On July 27, 2026, it was announced that J&J would pay $5.5 billion to settle a multitude of lawsuits alleging that its talc-based baby powder caused cancer. This settlement came after a history of shareholder engagement on the issue. In 2022, a shareholder resolution called for J&J to cease the global sales of its talc-based baby powder, citing mounting cancer litigation, concerns over asbestos contamination, and escalating financial risks.
Despite these explicit warnings from investors, J&J’s management maintained that "decades of science have reaffirmed its safety" and that the company had implemented adequate measures to address litigation. The Board’s opposition to the shareholder proposal resulted in it receiving only 15.6% of the vote. The eventual settlement, with a potential total cost exceeding $7 billion depending on claimant participation, underscores the significant financial burden incurred by the company and its shareholders due to a failure to address the issue proactively.
Monsanto/Bayer: Glyphosate Risks and Dismissed Science
The saga of Monsanto (now part of Bayer) and its glyphosate-based products, most notably Roundup, provides another compelling case study. In February 2026, Monsanto announced a class settlement agreement to resolve current and future claims related to Roundup, with an estimated cost of up to $7.25 billion. Shareholders had repeatedly raised concerns about the risks associated with glyphosate, submitting proposals in 2015, 2016, and 2018. These proposals urged Monsanto to report on the potential risks, including those stemming from the International Agency for Research on Cancer (IARC) classification of glyphosate as "probably carcinogenic to humans."
In each instance, Monsanto’s Board opposed these proposals. The company’s defense centered on the assertion that "the purported harms suggested in the proposal are simply unsubstantiated and unproven assertions improperly characterized as risks." Management argued that the requested risk analysis was therefore speculative and unnecessary. The acquisition of Monsanto by Bayer in 2018 meant that Bayer inherited the ongoing litigation and the substantial financial liabilities associated with Roundup. The substantial settlement in 2026 represents a significant financial blow, highlighting the cost of ignoring scientific warnings and investor concerns that were voiced years prior.
Meta’s Second Major Settlement: Children’s Online Safety
The year 2026 also saw Meta facing an unprecedented $18 billion settlement to resolve U.S. lawsuits concerning children’s social media addiction. This settlement, announced in August, represents a substantial 9% of Meta’s annual revenue and followed $2.4 billion in legal-proceeding charges recorded in the second quarter, which contributed to a 55% increase in total costs and expenses to $42.03 billion.
Shareholders had been actively engaging Meta on the risks associated with child safety online since 2020. A proposal filed that year requested a report addressing the potential adverse impacts on children and the company’s reputation, along with an assessment of detection technologies and strategies. The Board’s dismissal of this proposal as "unnecessary and not beneficial to our stockholders" led to only 12.4% of the vote. The issue persisted, with shareholders refiling the proposal in 2022. Despite continued Board opposition, it garnered 56.7% support from independent shareholders, though the company’s dual-class share structure limited its overall impact to 17.3% of the total vote. The financial penalties were not limited to this massive settlement; in the same year, Meta was fined $400 million for failing to adequately protect children’s privacy on Instagram. Throughout 2023, 2024, and 2025, shareholders continued to raise these concerns, but the Board’s consistent opposition and the voting structure obstructed meaningful change. The question remains: could a more responsive approach to these shareholder proposals have averted such significant harm to children, the company, and its investors?
The Value of Shareholder Proposals as an Early Warning System
These extensive financial repercussions, totaling over $30 billion for just three companies in 2026, underscore the critical role of shareholder proposals as an "early warning system" for material corporate risks. When unheeded, these warnings can lead to profound harm affecting individuals, the environment, shareholders, and a company’s bottom line. The instances detailed above demonstrate a recurring pattern: investors identify significant risks, propose solutions through formal resolutions, and are met with managerial resistance, only to face substantial financial penalties and reputational damage when those risks materialize.
The current debate surrounding the costs and benefits of shareholder proposals often fails to adequately account for the value they provide in flagging potential crises. These proposals are not merely abstract exercises in corporate governance; they are often grounded in scientific evidence, legal challenges, and growing public concern. The dismissal of these concerns by corporate boards, particularly in companies with entrenched leadership or dual-class share structures that diminish the influence of independent shareholders, can have devastating consequences.
Implications for Corporate Governance and Investor Engagement
The recurring theme across these high-profile cases is the disconnect between shareholder concerns and board responses. In each instance, the Board’s opposition to shareholder proposals, often framed as unnecessary or unsubstantiated, directly preceded significant financial penalties. This pattern suggests a systemic issue within corporate governance where management and boards may become insular, failing to adequately weigh the long-term implications of risks that have been clearly articulated by their investors.
The dual-class share structure, as seen with Meta, exacerbates this problem by concentrating voting power and insulating management from accountability to a broader shareholder base. While such structures may be intended to provide long-term strategic stability, they can also stifle necessary change and prevent the incorporation of diverse perspectives, including those of investors who bear the financial consequences of poor decision-making.
The Road Ahead: Rethinking Board Scrutiny
The substantial financial costs incurred by Meta, Johnson & Johnson, and Monsanto/Bayer serve as a potent reminder of the value of shareholder resolutions. These resolutions are not simply a mechanism for shareholder activism; they represent a crucial tool for identifying and mitigating material corporate risks. Boards of directors must therefore grant these proposals more thorough scrutiny, recognizing them as valuable insights into potential future liabilities.
The billions of dollars in fines and settlements serve as a stark testament to the tangible cost of ignoring investor foresight. Moving forward, a more responsive and engaged corporate governance framework that genuinely considers and acts upon shareholder concerns is essential to safeguard not only shareholder value but also the well-being of individuals and the broader societal impact of corporate actions. The year 2026 has provided a costly, yet vital, lesson in the financial and ethical imperative of heeding the warnings from those who have a vested interest in a company’s long-term sustainability and responsible operation.
